223 related articles for article (PubMed ID: 32811698)
1. Prediction of the invasive level of basal cell carcinomas in the facial area: Analysis of 718 Japanese cases.
Matsushita S; Nakamura Y; Tanaka R; Araki R; Yamamura K; Yoshioka M; Inoue A; Komori T; Saito S; Teramoto Y; Nakamura Y; Fujisawa Y; Aoki M
J Dermatol Sci; 2020 Sep; 99(3):152-157. PubMed ID: 32811698
[TBL] [Abstract][Full Text] [Related]
2. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
Cerci FB; Kubo EM; Werner B; Tolkachjov SN
J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
[TBL] [Abstract][Full Text] [Related]
3. Basal cell carcinomas of the ear are more aggressive and have higher discordance rates between biopsy and Mohs histopathology.
Navrazhina K; Parra CE; Cressey BD; Xanthos C; Christos PJ; Minkis K
J Am Acad Dermatol; 2020 Dec; 83(6):1805-1807. PubMed ID: 32289399
[No Abstract] [Full Text] [Related]
4. How Wide Should the Excision Margins for Facial Small Aggressive Basal Cell Carcinoma Be? Experience With 306 Cases.
Ariza SA; Calderón DC; Aristizábal JC; Parra-Medina R
Dermatol Surg; 2020 Jun; 46(6):753-756. PubMed ID: 31567587
[TBL] [Abstract][Full Text] [Related]
5. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
van Kester MS; Goeman JJ; Genders RE
J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
[TBL] [Abstract][Full Text] [Related]
6. Surgical Treatment of Facial Basal Cell Carcinoma: Patient-Based Assessment of Clinical Outcome in a Prospective Cohort Study.
Ofaiche J; Lopez R; Bérard E; André A; Bulai-Livideanu C; Méresse T; Vairel BB; Grolleau JL; Paul C; Meyer N
Dermatology; 2016; 232(5):550-557. PubMed ID: 27676268
[TBL] [Abstract][Full Text] [Related]
7. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases].
Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V
Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511
[TBL] [Abstract][Full Text] [Related]
8. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study.
Sin CW; Barua A; Cook A
Int J Dermatol; 2016 Sep; 55(9):1044-7. PubMed ID: 27152747
[TBL] [Abstract][Full Text] [Related]
9. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
Kiely JR; Patel AJK
J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
[TBL] [Abstract][Full Text] [Related]
11. [Basaliomas].
Schubert J
Mund Kiefer Gesichtschir; 2000 May; 4 Suppl 1():S169-76. PubMed ID: 10938657
[TBL] [Abstract][Full Text] [Related]
12. Basal cell carcinoma treated with Mohs micrographic surgery in young Ibero-American patients.
Aluma-Tenorio MS; Ávila-Álvarez A; Jaimes N; Caballero-Uribe N; González A; Terzian LR; Ocampo-Candiani J; Zuluaga MA; Garza-Rodríguez V; Tamayo-Betancur MC; Cuesta-Castro DP; Garcés JR; Ruiz-Salas V; Goldberg L; Kimyai-Asadi A
Int J Dermatol; 2018 Dec; 57(12):1447-1453. PubMed ID: 30168850
[TBL] [Abstract][Full Text] [Related]
13. The use of Mohs surgery in facial tumors in a patient with Darier's disease.
Hamadah I; Grande DJ
J Dermatol Surg Oncol; 1991 Dec; 17(12):950-3. PubMed ID: 1960266
[TBL] [Abstract][Full Text] [Related]
14. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
15. Dermoscopic Findings in the Presurgical Evaluation of Basal Cell Carcinoma. A Prospective Study.
Conforti C; Giuffrida R; Zalaudek I; Guarneri F; Cannavò SP; Pizzichetta MA; Bonin S; Corneli P; Bussani R; Bazzacco G; Di Meo N
Dermatol Surg; 2021 Feb; 47(2):e37-e41. PubMed ID: 32804889
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for local recurrence of basal cell carcinoma and cutaneous squamous cell carcinoma of the middle third of the face: a 15-year retrospective analysis based on a single centre.
Bourlidou E; Vahtsevanos K; Kyrgidis A; Tilaveridis I; Patsatsi A; Andreadis D; Cheva A; Patrikidou A; Kitikidou K; Boboridis K
Eur J Dermatol; 2019 Oct; 29(5):490-499. PubMed ID: 31789273
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.
Kimyai-Asadi A; Alam M; Goldberg LH; Peterson SR; Silapunt S; Jih MH
J Am Acad Dermatol; 2005 Sep; 53(3):464-8. PubMed ID: 16112354
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathologic parameters predicting recurrence of facial basal cell carcinoma: a retrospective audit in an advanced care center.
Troeltzsch M; Probst FA; Knösel T; Mast G; Ehrenfeld M; Otto S
Int J Dermatol; 2016 Nov; 55(11):1281-1288. PubMed ID: 27420481
[TBL] [Abstract][Full Text] [Related]
19. Increased Marginal Stiffness Differentiates Infiltrative From Noninfiltrative Cutaneous Basal Cell Carcinomas in the Facial Area: A Prospective Study.
Alfageme F; Salgüero I; Nájera L; Suarez ML; Roustan G
J Ultrasound Med; 2019 Jul; 38(7):1841-1845. PubMed ID: 30467885
[TBL] [Abstract][Full Text] [Related]
20. Attributes and risk factors of positive margins on 864 excisions of basal cell carcinomas: a single-center retrospective study.
Filho RB; de Carvalho Fantini B; Dos Santos CA; Melo RVG; Rosan I; Chahud F; da Silva Souza C
J Dermatolog Treat; 2020 Sep; 31(6):589-596. PubMed ID: 31751157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
